BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 22036137)

  • 1. Are patients with the symptoms of overactive bladder and urodynamic detrusor overactivity different from those with overactive bladder but not detrusor overactivity?
    Fan YH; Lin CC; Lin AT; Chen KK
    J Chin Med Assoc; 2011 Oct; 74(10):455-9. PubMed ID: 22036137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and urodynamic impact of detrusor overactivity in women with overactive bladder.
    Jiménez-Cidre MA; López-Fando L; Mora AM;
    Actas Urol Esp (Engl Ed); 2019 Jun; 43(5):221-227. PubMed ID: 30862379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a difference between women with or without detrusor overactivity complaining of symptoms of overactive bladder?
    Giarenis I; Mastoroudes H; Srikrishna S; Robinson D; Cardozo L
    BJU Int; 2013 Aug; 112(4):501-7. PubMed ID: 23452071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overactive bladder syndrome - focus onto detrusor overactivity.
    Ptashnyk T; Hatzinger M; Zeller FL; Kirschner-Hermanns R
    Scand J Urol; 2021 Feb; 55(1):56-60. PubMed ID: 33118417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
    Dokmeci F; Cetinkaya SE; Seval MM; Dai O
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urodynamic Efficacy and Safety of Mirabegron Add-on Treatment with Tamsulosin for Japanese Male Patients with Overactive Bladder.
    Wada N; Iuchi H; Kita M; Hashizume K; Matsumoto S; Kakizaki H
    Low Urin Tract Symptoms; 2016 Sep; 8(3):171-6. PubMed ID: 27619782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining Causes for Overactive Bladder Symptoms in Women.
    Fan YH; Lin AT; Chen KK
    Low Urin Tract Symptoms; 2012 May; 4(2):73-6. PubMed ID: 26676529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there any association between urodynamic variables and severity of overactive bladder in women with idiopathic detrusor overactivity?
    Giarenis I; Zacchè M; Robinson D; Cardozo L
    Neurourol Urodyn; 2017 Mar; 36(3):780-783. PubMed ID: 27092808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of urodynamic results and quality of life between women with interstitial cystitis and overactive bladder.
    Hsu CC; Liang CC; Chang SD; Chien CW; Hsieh WC
    Taiwan J Obstet Gynecol; 2020 Jan; 59(1):39-42. PubMed ID: 32039798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urgency severity scale could predict urodynamic detrusor overactivity in patients with overactive bladder syndrome.
    Chung SD; Liao CH; Chen YC; Kuo HC
    Neurourol Urodyn; 2011 Sep; 30(7):1300-4. PubMed ID: 21560153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there concordance between overactive bladder and detrusor overactivity in men with predominant storage urinary symptoms referred to Functional Urology and Urodynamics Units?
    Esteban-Fuertes M; Prieto-Chaparro L; Arlandis-Guzmán S; Salinas-Casado J; Gago-Ramos JL;
    Actas Urol Esp (Engl Ed); 2022; 46(1):41-48. PubMed ID: 34848162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the overactive bladder symptom score and the overactive bladder symptom score derived from the bladder diaries.
    Hikita KS; Honda M; Hirano S; Kawamoto B; Panagiota T; Muraoka K; Sejima T; Takenaka A
    Neurourol Urodyn; 2016 Mar; 35(3):349-53. PubMed ID: 25597478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The translation and validation of Chinese overactive bladder symptom score for assessing overactive bladder syndrome and response to solifenacin treatment.
    Chou EC; Hung MJ; Yen TW; Chuang YC; Meng E; Huang ST; Kuo HC
    J Formos Med Assoc; 2014 Aug; 113(8):506-12. PubMed ID: 25037757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence of mesh pelvic floor reconstructive surgery on OAB symptoms].
    Nowakowski L; Wróbel A; Jankiewicz K; Kulik-Rechberger B; Rechberger T
    Ginekol Pol; 2014 Oct; 85(10):760-4. PubMed ID: 25546927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urodynamic findings in women with refractory overactive bladder symptoms.
    Al-Zahrani AA; Gajewski J
    Int J Urol; 2016 Jan; 23(1):75-9. PubMed ID: 26417863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of the Polish version of the Overactive Bladder Symptom Score (OABSS) questionnaire : Correlation of the OABSS with urodynamic study and the UDI-6 and IIQ-7 questionnaires.
    Wróbel A; Skorupska K; Rechberger E; Woźniak A; Miotla P; Kubik-Komar A; Skorupski P; Rechberger T
    Int Urogynecol J; 2019 Dec; 30(12):2135-2139. PubMed ID: 31396639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of female overactive bladder using urodynamics: relationship with female voiding dysfunction.
    Cho KJ; Kim HS; Koh JS; Kim JC
    Int Braz J Urol; 2015; 41(4):722-8. PubMed ID: 26401865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of overactive bladder symptoms after tension-free vaginal mesh operation in women with pelvic organ prolapse: Correlation with preoperative urodynamic findings.
    Tomoe H
    Int J Urol; 2015 Jun; 22(6):577-80. PubMed ID: 25754989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urodynamic evaluation of the efficacy of mirabegron on storage and voiding functions in women with overactive bladder.
    Matsukawa Y; Takai S; Funahashi Y; Yamamoto T; Gotoh M
    Urology; 2015 Apr; 85(4):786-90. PubMed ID: 25709050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of botulinum toxin-A in refractory idiopathic overactive bladder patients without detrusor overactivity.
    Kanagarajah P; Ayyathurai R; Caruso DJ; Gomez C; Gousse AE
    Int Urol Nephrol; 2012 Feb; 44(1):91-7. PubMed ID: 21643644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.